The Role of Radiotherapy in Epidermal Growth Factor Receptor Mutation-positive Patients with Oligoprogression: A Matched-cohort Analysis

Clinical Oncology : a Journal of the Royal College of Radiologists
O S H ChanR M W Yeung

Abstract

Almost all patients with epidermal growth factor receptor (EGFR) mutations will develop resistance to first-line EGFR tyrosine kinase inhibitors (TKIs). The management of oligoprogression on EGFR TKI is controversial. Irradiating progressing tumours may potentially eradicate the resistant clone and allow continuation of EGFR TKI, but the clinical data remain sparse. We aimed to assess the effect of radiotherapy on survival outcomes in patients with oligoprogression in a matched-cohort study. This was a retrospective matched-cohort study comparing patients with EGFR mutation-positive stage IV non-small cell lung cancer receiving radiotherapy versus chemotherapy for progression. Patients in the radiotherapy group received radiotherapy (mainly stereotactic ablative radiotherapy) for oligoprogression, whereas the chemotherapy group received only systemic chemotherapy upon progression. Key prognostic factors including gender, age, performance status, time to first progression and mutation subtypes were matched. Twenty-five patients with oligoprogression (radiotherapy group) were identified, and a matched chemotherapy group with the same number of patients was generated. The median duration of follow-up was 24.3 and 34 months for the...Continue Reading

Citations

Sep 28, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ralph R Weichselbaum
Aug 15, 2019·Future Oncology·Tommaso PorcelliDomenico Salvatore
Jan 11, 2019·Journal of Endocrinological Investigation·T PorcelliD Salvatore
Oct 30, 2020·International Journal of Radiation Oncology, Biology, Physics·Jeevin ShahiPatrick Cheung
Jan 15, 2020·Deutsches Ärzteblatt International·Jan HaussmannWilfried Budach
Apr 24, 2019·Revue des maladies respiratoires·P GustinA Levy
Sep 10, 2019·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·C BourgierD Azria
Jun 7, 2021·Seminars in Radiation Oncology·Zachary MorrisRobert Timmerman
Jun 12, 2019·Clinical Oncology : a Journal of the Royal College of Radiologists·P H PatelA C Tree

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.